Related Experiment Video
Updated: Jan 22, 2026

10:51
Evaluating Primary Blast Effects In Vitro
Published on: September 18, 2017
8.4K
Evaluation and Management of Primary Hyperaldosteronism
1Department of General Surgery, Northwestern University Feinberg School of Medicine, 675 North Saint Clair Street, Suite 3-150, Chicago, IL 60611, USA.
The Surgical Clinics of North America
|July 1, 2019
Summary
Primary hyperaldosteronism, a common hypertension cause, involves excess aldosterone. Diagnosis requires screening, confirmation, and subtype classification using imaging and adrenal vein sampling for effective management.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Primary hyperaldosteronism is a prevalent and significant cause of hypertension.
- It is characterized by the adrenal glands producing too much aldosterone.
- Over 90% of cases stem from idiopathic adrenal hyperplasia or aldosterone-producing adenomas.
Purpose of the Study:
- To outline a diagnostic strategy for primary hyperaldosteronism.
- To emphasize the importance of subtype classification for treatment decisions.
- To clarify the role of imaging and adrenal vein sampling (AVS) in diagnosis.
Main Methods:
- A step-wise diagnostic approach is recommended.
- Screening at-risk populations is the initial step.
- Confirmatory testing follows positive screening, with subtype classification using imaging and AVS.
Main Results:
- The diagnostic pathway involves screening, confirmation, and subtype classification.
- Idiopathic adrenal hyperplasia and aldosterone-producing adenomas are the primary causes.
- Adrenal vein sampling (AVS) is crucial for subtype classification, with exceptions for specific patient groups.
Conclusions:
- A structured diagnostic approach is essential for primary hyperaldosteronism.
- Accurate subtype classification guides appropriate surgical or medical management.
- Imaging and AVS are key components of the diagnostic workup.
Related Concept Videos
Impression Management Techniques I: Managing Appearances
202
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
202
Tonsillitis II: Management
409
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
409
Management of Insomnia
558
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
558
Managing Impressions
164
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
164
Cystic Fibrosis: Management
485
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
485
Angina IV: Management
249
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
249

